---
$id: https://graph.org.ai/products/commodity/51151657
$type: Product
source: UNSPSC
code: "51151657"
title: "Oxybutynin"
class: "51151600"
classTitle: "Cholinergic blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Oxybutynin

**UNSPSC Code**: 51151657
**Class**: [Cholinergic blocking agents](Cholinergic blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antimuscarinic agent with the molecular formula C22H31NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K9P6MC7092, chemically known as cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester but generally known as oxybutynin, which bears US NIH Compound Identifier 4634. European Medicines Agency schedules Oxybutynin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09558MIG. The term OXYBUTYNIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules oxybutynin in its Anatomical Therapeutic Chemical (ATC) Classification. OXYBUTYNIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule oxybutynin under HS 29221980 and SITC 51461. As of Q4 2014, OXYBUTYNIN remains the US FDA Preferred Term for this commodity. Oxybutynin bears US NLM identifiers UMLS ID C0069805 and NCI Concept Code C47647. SMILES: OC(C1CCCCC1)(C1CCCCC1)C(=O)OCC#CCN(CC)CC.

